0|chunk|molecules Silver Nanoparticles as Potential Antiviral Agents
0	0	9 molecules	Chemical	CHEBI_25367
0	10	16 Silver	Chemical	CHEBI_30512
0	10	30 Silver Nanoparticles	Chemical	CHEBI_50826
0	17	30 Nanoparticles	Chemical	CHEBI_50803
0	44	53 Antiviral	Chemical	CHEBI_22587
0	44	60 Antiviral Agents	Chemical	CHEBI_22587
0	CHEBI-CHEBI	CHEBI_25367	CHEBI_30512
0	CHEBI-CHEBI	CHEBI_25367	CHEBI_50826
0	CHEBI-CHEBI	CHEBI_25367	CHEBI_50803
0	CHEBI-CHEBI	CHEBI_25367	CHEBI_22587
0	CHEBI-CHEBI	CHEBI_30512	CHEBI_50826
0	CHEBI-CHEBI	CHEBI_30512	CHEBI_50803
0	CHEBI-CHEBI	CHEBI_30512	CHEBI_22587
0	CHEBI-CHEBI	CHEBI_50826	CHEBI_50803
0	CHEBI-CHEBI	CHEBI_50826	CHEBI_22587
0	CHEBI-CHEBI	CHEBI_50803	CHEBI_22587

1|chunk|Virus infections pose significant global health challenges, especially in view of the fact that the emergence of resistant viral strains and the adverse side effects associated with prolonged use continue to slow down the application of effective antiviral therapies. This makes imperative the need for the development of safe and potent alternatives to conventional antiviral drugs. In the present scenario, nanoscale materials have emerged as novel antiviral agents for the possibilities offered by their unique chemical and physical properties. Silver nanoparticles have mainly been studied for their antimicrobial potential against bacteria, but have also proven to be active against several types of viruses including human imunodeficiency virus, hepatitis B virus, herpes simplex virus, respiratory syncytial virus, and monkey pox virus. The use of metal nanoparticles provides an interesting opportunity for novel antiviral therapies. Since metals may attack a broad range of targets in the virus there is a lower possibility to develop resistance as compared to conventional antivirals. The present review focuses on the development of methods for the production of silver nanoparticles and on their use as antiviral therapeutics against pathogenic viruses.
1	247	256 antiviral	Chemical	CHEBI_22587
1	367	376 antiviral	Chemical	CHEBI_22587
1	451	460 antiviral	Chemical	CHEBI_22587
1	451	467 antiviral agents	Chemical	CHEBI_22587
1	548	554 Silver	Chemical	CHEBI_30512
1	548	568 Silver nanoparticles	Chemical	CHEBI_50826
1	555	568 nanoparticles	Chemical	CHEBI_50803
1	604	617 antimicrobial	Chemical	CHEBI_33281
1	861	874 nanoparticles	Chemical	CHEBI_50803
1	921	930 antiviral	Chemical	CHEBI_22587
1	948	954 metals	Chemical	CHEBI_33521
1	1174	1180 silver	Chemical	CHEBI_30512
1	1174	1194 silver nanoparticles	Chemical	CHEBI_50826
1	1181	1194 nanoparticles	Chemical	CHEBI_50803
1	1215	1224 antiviral	Chemical	CHEBI_22587
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_30512
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_50826
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_50803
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_33281
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_33521
1	CHEBI-CHEBI	CHEBI_30512	CHEBI_50826
1	CHEBI-CHEBI	CHEBI_30512	CHEBI_50803
1	CHEBI-CHEBI	CHEBI_30512	CHEBI_33281
1	CHEBI-CHEBI	CHEBI_30512	CHEBI_33521
1	CHEBI-CHEBI	CHEBI_50826	CHEBI_50803
1	CHEBI-CHEBI	CHEBI_50826	CHEBI_33281
1	CHEBI-CHEBI	CHEBI_50826	CHEBI_33521
1	CHEBI-CHEBI	CHEBI_50803	CHEBI_33281
1	CHEBI-CHEBI	CHEBI_50803	CHEBI_33521
1	CHEBI-CHEBI	CHEBI_33281	CHEBI_33521

2|chunk|Molecules 2011, 16 8895
2	0	9 Molecules	Chemical	CHEBI_25367

